Continuous epidermal growth factor receptor-tyrosine kinase inhibitor administration in primary lung adenocarcinoma patients harboring favorable mutations with controlled target lung tumors dose not hinder survival benefit despite small new lesions.
| Image |  |
|---|---|
| Description | scientific article published on April 2016 |
| Author/s |
author: Cheng-Ta Yang Chih-Hung Chen |
| Publication date | April 1, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |